The importance of pre-approval information exchange (PIE) with payers and other strategic considerations to help navigate today’s market access challenges and regulatory requirements in bringing promising cell and gene therapies to the market.
Lung-I Cheng, PhD
Advertisement
Vice President and Head of Cell & Gene Therapy Service Line, Cencora
Articles by Lung-I Cheng, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Stock Reacts to Recent Board Changes
2
Bob Mauch: Strengthening the Chain
3
MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators
4
mRNA Covid Vaccines Display Potential to Benefit Immunotherapy Cancer Drugs
5
